These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 28635713)

  • 1. [Intravenous immunoglobulins: perspectives in multiple sclerosis (a literature review with own results)].
    Bisaga GN; Skulyabin ID; Popov AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8. Vyp. 2):36-43. PubMed ID: 28635713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis.
    Brandt-Wouters E; Gerlach OH; Hupperts RM
    Int J Gynaecol Obstet; 2016 Aug; 134(2):194-6. PubMed ID: 27177509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials.
    Sørensen PS
    Neurol Sci; 2003 Oct; 24 Suppl 4():S227-30. PubMed ID: 14598048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness assessment of intravenous immunoglobulin in the treatment of relapsing-remitting multiple sclerosis: A meta-analysis.
    Olyaeemanesh A; Rahmani M; Goudarzi R; Rahimdel A
    Med J Islam Repub Iran; 2016; 30():336. PubMed ID: 27390706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-dose intravenous immunoglobulins in the treatment of multiple sclerosis. An update].
    Stangel M; Gold R
    Nervenarzt; 2005 Oct; 76(10):1267, 1269-70, 1272. PubMed ID: 15902390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment effects of monthly intravenous immunoglobulin on patients with relapsing-remitting multiple sclerosis: further analyses of the Austrian Immunoglobulin in MS study.
    Fazekas F; Deisenhammer F; Strasser-Fuchs S; Nahler G; Mamoli B
    Mult Scler; 1997 Apr; 3(2):137-41. PubMed ID: 9291168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous polyclonal human immunoglobulins in multiple sclerosis.
    Soelberg Sorensen P
    Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
    Martinez V; Cohen P; Pagnoux C; Vinzio S; Mahr A; Mouthon L; Sailler L; Delaunay C; Sadoun A; Guillevin L;
    Arthritis Rheum; 2008 Jan; 58(1):308-17. PubMed ID: 18163506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.
    Visser LH; Beekman R; Tijssen CC; Uitdehaag BM; Lee ML; Movig KL; Lenderink AW
    Mult Scler; 2004 Feb; 10(1):89-91. PubMed ID: 14760960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum IgG subclass concentrations before and after administration of intravenous immunoglobulin in common variable immunodeficiency.
    Ozawa T; Motoyoshi F; Kato Y; Kondo N; Orii T
    J Clin Lab Immunol; 1992; 38(1):29-39. PubMed ID: 1343346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
    Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulins in the treatment of relapsing remitting multiple sclerosis--results of a retrospective multicenter observational study over five years.
    Haas J; Maas-Enriquez M; Hartung HP
    Mult Scler; 2005 Oct; 11(5):562-7. PubMed ID: 16193894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products.
    Etscheid M; Breitner-Ruddock S; Gross S; Hunfeld A; Seitz R; Dodt J
    Vox Sang; 2012 Jan; 102(1):40-6. PubMed ID: 21545600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin in MS: promise or failure?
    Fazekas F; Strasser-Fuchs S; Hommes OR
    J Neurol Sci; 2007 Aug; 259(1-2):61-6. PubMed ID: 17449063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Immunoglobulins in MS.
    Stangel M; Gold R
    Int MS J; 2005 Apr; 12(1):5-10, 4. PubMed ID: 15955273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial.
    Hommes OR; Sørensen PS; Fazekas F; Enriquez MM; Koelmel HW; Fernandez O; Pozzilli C; O'Connor P
    Lancet; 2004 Sep 25-Oct 1; 364(9440):1149-56. PubMed ID: 15451222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical-based assays in the bioanalysis of immunoglobulins.
    Lamari F; Anastassiou ED; Dimitracopoulos G; Karamanos NK
    J Pharm Biomed Anal; 2000 Nov; 23(6):939-46. PubMed ID: 11095294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ;
    Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria for the appropriate drug utilisation of immunoglobulin.
    Thürmann P; Harder S
    Pharmacoeconomics; 1996 May; 9(5):417-29. PubMed ID: 10160254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous immunoglobulins for relapsing-remitting multiple sclerosis after failure of treatment with other immuno-modulators].
    Lebrun C; Ghetau G; Bourg V; Chanalet S; Dumas S; Chatel M
    Rev Neurol (Paris); 2003 Jul; 159(6-7 Pt 1):648-51. PubMed ID: 12910072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.